ASP Isotopes (NASDAQ:ASPI) Shares Up 7.1% – Still a Buy?

ASP Isotopes Inc. (NASDAQ:ASPI)’s share price rose 7.1% on Friday . The stock traded as high as $4.14 and last traded at $4.1750. 1,272,407 shares traded hands during mid-day trading, a decline of 73% from the average daily volume of 4,760,408 shares. The stock had previously closed at $3.90.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on ASPI shares. Wall Street Zen upgraded ASP Isotopes from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 22nd. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research note on Wednesday, June 24th. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $13.00.

ASP Isotopes Trading Up 7.6%

The company’s fifty day simple moving average is $4.41 and its 200-day simple moving average is $5.21. The firm has a market capitalization of $643.14 million, a PE ratio of -3.19 and a beta of 3.59. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.87 and a quick ratio of 3.85.

ASP Isotopes (NASDAQ:ASPI) last released its earnings results on Friday, August 14th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.11). ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.The company had revenue of $5.12 million for the quarter, compared to analysts’ expectations of $4.47 million.

Insider Transactions at ASP Isotopes

In other ASP Isotopes news, CFO Heather Kiessling sold 23,124 shares of the stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $6.28, for a total transaction of $145,218.72. Following the completion of the transaction, the chief financial officer owned 1,526,252 shares of the company’s stock, valued at $9,584,862.56. This represents a 1.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Todd Wider sold 50,000 shares of ASP Isotopes stock in a transaction that occurred on Monday, June 29th. The stock was sold at an average price of $6.25, for a total value of $312,500.00. Following the completion of the sale, the director directly owned 722,247 shares in the company, valued at $4,514,043.75. This represents a 6.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 111,562 shares of company stock valued at $704,885 in the last 90 days. Corporate insiders own 14.40% of the company’s stock.

Institutional Investors Weigh In On ASP Isotopes

Large investors have recently modified their holdings of the business. State of Wyoming acquired a new stake in shares of ASP Isotopes in the first quarter valued at about $29,000. Quantbot Technologies LP acquired a new position in ASP Isotopes during the third quarter worth about $34,000. BNP Paribas Financial Markets grew its stake in ASP Isotopes by 84.9% during the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock valued at $41,000 after acquiring an additional 2,548 shares in the last quarter. Stephens Inc. AR purchased a new stake in ASP Isotopes during the 1st quarter valued at about $44,000. Finally, Broadhurst Jeffrey B acquired a new stake in ASP Isotopes in the 1st quarter valued at about $44,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.